Researchers developed a series of light-activated small molecule drugs that mimic the function of the light-sensing photoreceptor cells that degenerate in diseases such as age-related macular degeneration and retinitis pigmentosa, and which in tests restored sight in blind mice. The post See, Blind Mice: Consortium’s Drugs Restore Sight appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
StockWatch: Lilly’s Up-to-$3.8B Deal for AtaiBeckley...
Organ Aging Linked to Breakdown in Immune Cell...
Biotronik Neuro snaps up spinal cord stimulation...
Why Commercial Evidence Is the Next Breakthrough in...
Operating at the speed of science: The new medical...
Why modern clinical trials need a finance-first...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
